January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Thor Halfdanarson: Radiosensitivity of NET in Locally Advanced G2 Pancreatic Tumor Treated with CAPTEM and CRT
Jan 30, 2025, 17:27

Thor Halfdanarson: Radiosensitivity of NET in Locally Advanced G2 Pancreatic Tumor Treated with CAPTEM and CRT

Thor Halfdanarson, Vice President of the North American Neuroendocrine Tumor Society, shared on X:

“A reminder that NETs are radiosensitive tumors. Locally advanced, nonmetastatic, unresectable (extensive vascular involvement, cavernous portal vein transformation) G2 panc NET (Ki67 9%). CAPTEM x12 with good partial response, followed by CRT with capecitabine. 23 months post CRT.”

Thor Halfdanarson: Radiosensitivity of NET in Locally Advanced G2 Pancreatic Tumor Treated with CAPTEM and CRT

More posts featuring Thor Halfdanarson.